IVF is the ticker symbol for INVO Fertility, Inc., a publicly traded Healthcare sector company listed on Nasdaq. 13F Pro tracks IVF with AI-powered analysis, a 32-signal quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Is IVF a good stock to buy?

IVF is tracked on 13F Pro with SEC EDGAR data, but is not currently included in our 32-signal AI quality ranking. The full company profile with financials and AI insights is at https://13fpro.ai/company/IVF.

Where does 13F Pro source IVF data?

All INVO Fertility, Inc. fundamentals and ownership data come directly from SEC EDGAR. INVO Fertility, Inc. files with the SEC under CIK 1417926. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

INVO Fertility, Inc.(IVF)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

INVO Fertility, Inc. (IVF) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. IVF is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $6.8m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), INVO Fertility, Inc. reports quarterly revenue of $2.2M, net income of $888.7K. Top institutional holders of IVF by reported 13-F value include Virtu Financial, Scientech Research, StoneX Group, based on the most recent SEC filings. IVF trades on the Nasdaq exchange and files with the SEC under CIK 1417926. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IVF daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for INVO Fertility, Inc. directly from SEC EDGAR.

Revenue

$2.2M

Net Income

$888.7K

IVF key financials by period

INVO Fertility, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
Period	Form	Revenue	Net income	Operating margin
FY 2025	10-K	$6.8M	$-23.3M	-105.8%
FY 2024	10-K	$6.5M	$-9.3M	-101.5%
FY 2023	10-K/A	$3.0M	$-8.0M	—
FY 2022	10-K/A	$822.2K	$-10.9M	—
FY 2021	10-K/A	$4.2M	$-6.7M	-125.4%
FY 2020	10-K	$1.0M	$-8.3M	—

Institutions holding IVF

Institutional investors reporting a position in INVO Fertility, Inc. on SEC Form 13F.
Institution	Shares	Value	Reported
Virtu Financial	63,174	$120.0K	2026-06-30
Scientech Research	32,338	$61.4K	2026-06-30
StoneX Group	15,702	$29.8K	2026-06-30
SUSQUEHANNA INTERNATIONAL GROUP, LLP	11,463	$21.8K	2026-06-30
Tower Research Capital (TRC)	8,155	$15.5K	2026-06-30
SBI Securities , Ltd.	53	$101.00	2026-06-30
Caitong International Asset Management , Ltd	38	$72.00	2026-06-30
Integrated Wealth Concepts	8	$15.00	2026-06-30
DANSKE BANK A/S	1	$2.00	2026-06-30
HUNTINGTON NATIONAL BANK	1	$0.00	2026-06-30

SEC EDGAR: CIK 1417926 →

INVO Fertility, Inc.

IVF

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $6.8M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.